182

 

1.      De Bacquer D, De Backer G, Kornitzer M. Prevalences of ECG findings in large population based samples of men and women. Heart. 2000;84:625–633. 

2.      Deal BJ, Keane JF, Gillette PC, Garson A Jr. Wolff-Parkinson-White syndrome and supraventricular tachycardia during infancy: management and follow-up. J Am Coll Cardiol. 1985;5:130–135.

3.      Hoffman TM, Bush DM, Wernovsky G, et al. Postoperative junctional ectopic tachycardia in children: incidence, risk factors, and treatment. Ann Thorac Surg. 2002;74:1607–1611.

4.      Kang KT, Potts JE, Radbill AE, et al. Permanent junctional reciprocating tachycardia in children: a multicenter experience. Heart Rhythm. 2014;11(8):1426–1432.

5.      Ko K, Deal BJ, Strasburger JF, Benson DW Jr. Supraventricular tachycardia mechanisms and their age distribution in pediatric patients. Am J Cardiol. 1992;69:1028–1032.

6.      MacLellan-Tobert SG, Porter CJ. Accelerated idioventricular rhythm: a benign arrhythmia in childhood. Pediatrics. 1995;96:122–125.

7.      Moore JP, et al. Predictors of myocardial recovery in pediatric tachycardia-induced cardiomyopathy. Heart Rhythm. 2014;11(7):1163–1169.

8.      Morwood JG, Triedman JK, Berul CI, et al. Radiofrequency catheter ablation of ventricular tachycardia in children, and in young adults with congenital heart disease. Heart Rhythm 1:301, 2004.

9.      Perry JC, Garson A. Supraventricular tachycardia due to Wolff-Parkinson-White syndrome in children: early disappearance and late recurrence. J Am Coll Cardiol. 1990;16:1215–1220.

10. Pfammatter JP, Paul T. Idiopathic ventricular tachycardia in infancy and childhood: a multicenter study on clinical profile and outcome. Working Group on Arrhythmias and Electrophysiology of the Association for European Pediatric Cardiology. J Am Coll Cardiol. 1999;33:2067–2072.

11. Priori SG, Napolitano C, Schwartz PJ. Electrophysiologic mechanisms involved in the development of torsades de pointes. Cardiovasc Drugs Ther. 1991;5:203–212.

12. Riggs TW, Byrd JA, Weinhouse E. Recurrence risk of supraventricular tachycardia in pediatric patients. Cardiology. 1999;91:25–30.

13. Salerno JC, Kertesz NJ, Friedman RA, et al. Clinical course of atrial ectopic tachycardia is age dependent: results and treatment in children <3 or ≥3 years of age. J Am Coll Cardiol. 2004;43:438–444.

14. Singer DE, Albers GW, Dalen JE, et al.; American College of Chest Physicians. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 Suppl):546S–592S.

15. Song MK, Baek JS, Kwon BS, et al. Clinical spectrum and prognostic factors of pediatric ventricular tachycardia. Circ J. 2010;74:1953–1958.

16. Texter KM, Kertesz NJ, Friedman RA, Fenrich AL Jr. Atrial flutter in infants. J Am Coll Cardiol. 2006;48:1040–1046.

17. Weindling SN, Saul JP, Walsh EP. Risks and efficacy of medical therapy for supraventricular tachycardia in neonates and infants. Am Heart J 131:66, 1996.

ideasoft e-ticaret paketleri ile hazırlandı.